SlideShare a Scribd company logo
1 of 1
Download to read offline
Sensing Parainfluenza virus infection:
The role of RIG-I and MDA5
John A L Short, Rick Randall E-mail: jals4@st-andrews.ac.uk
Parainfluenza: The Essentials
What is a Parainfluenza virus?
 Parainfluenza virus (PIV) is a single stranded, RNA negative sense virus
 Infects the upper and lower respiratory tract
Who is at risk of infection?
 All children are infected at some stage
 Immunocompromised patients e.g. AIDS
What are the symptoms?
 Severe fever, coughing, sneezing, croup
There are NO antiviral drugs or vaccines
1
RIG-I and MDA5: viral sensors
RIG-I detects short double stranded viral RNA and 5’ triphosphate capped
single stranded viral RNA
MDA5 detects viral long double stranded viral RNA
RIG-I MDA5
IFNCell
Antiviral
IFN
2
Virus Infects Cell
RIG-I and MDA5 sensors
recognise viral RNA
Sensors activate pathway for
Interferon (IFN) expression
IFN is secreted & absorbed by
neighbouring uninfected cell
Cell expresses antivirals,
generating antiviral state
Inhibition of viral replication
upon viral infection
3 How do we visualise infection?
Plaque Assay
 Plaques formed from virus
spreading from infected cell to
neighbouring cells over 10 days
 Use cells that “knock down” or
decrease levels of RIG-I and MDA5
 2o Antibody conjugated to alkaline
phosphatase that reacts with
substrate to stain plaques black
 A549 NPro cells is a +ve control:
NPro inhibits IFN expression
Immunofluorescence
 Cells infected for 2 days
 Marker for IFN signalling to
neighbouring cells: cellular antiviral
MxA stained with Cy5
 Cells express Green Fluorescent
Protein (GFP) when IFN is induced
 2o Antibody conjugated to
fluorophore Texas Red
Plaque
2
MergeAnti-MxAAnti-PIV5GFP
Plaque
1
4
Mock
GFP +IFN-IFNAnti-PIV5
Immunofluorescence
- AIM: To determine the IFN response to PIV5 infection
Key: Green = GFP; Red = Viral NP;
Blue = Antiviral MxA
 Adding IFN to cells
induces expression of
antiviral MxA
 PIV5 infects cells,
forming a plaque
 No IFN induction =
no MxA expression
 IFN expressing cells
leads to induction of
MxA in neighbouring
uninfected cells
 Heterogeneous
cellular response:
Only some cells
express IFN, the
majority respond to IFN
signaling
 Infect monolayer of A549
alveolar epithelial cells with PIV5
NPro +ve
Control
Naïve MDA5 KD
RIG-I KD RIG-I/
MDA5 KD
0
0.5
1
1.5
2
2.5
3
Naïve
MDA5KD
RIG-IKD
RIG-
I/MDA5
KD
Npro+ve
Control
Relative sizes of largest plaques following
PIV5 infection
PlaquesizerelativetoNaive
5 Plaque Assay
- AIM: To visualise virus infection in cells lacking RIG-I and MDA5
 Naïve and MDA5 knock down (KD) cell lines had similar
plaque sizes after viral infection
 RIG-I and the RIG-I/MDA5 double KD cells had larger plaque
sizes than Naïve and MDA5 KD cells
 In RIG-I KD and RIG-I/MDA5 KD cells, plaques were
different sizes, indicating asynchronous viral IFN evasion
6 What does the data mean?
 IFN is expressed in some cells following virus infection
 Plaque assay data suggests that RIG-I is more important than MDA5 in
sensing PIV infection
The Future:
 Why is there a heterogeneous cellular response to virus infection?
 Are there differences in the number IFN expressing cells between RIG-I KD
and MDA5 KD cell lines?
7 Reference
Randall, R. E. and S. Goodbourn (2008). "Interferons and viruses: an interplay
between induction, signalling, antiviral responses and virus countermeasures."
J Gen Virol 89(Pt 1): 1-47.
 Stain cells with 1o antibody
for virus nucleoprotein

More Related Content

What's hot

What's hot (19)

SARS Corona-virus 2: Genome Sequencing And Its Application
SARS Corona-virus 2: Genome Sequencing And Its ApplicationSARS Corona-virus 2: Genome Sequencing And Its Application
SARS Corona-virus 2: Genome Sequencing And Its Application
 
Aids by ramkesh chauhan
Aids by ramkesh chauhanAids by ramkesh chauhan
Aids by ramkesh chauhan
 
Scientific Sessions 2015: HIV and genetics
Scientific Sessions 2015: HIV and geneticsScientific Sessions 2015: HIV and genetics
Scientific Sessions 2015: HIV and genetics
 
AIDS
AIDSAIDS
AIDS
 
Covid 19 neutralizing antibody microlisa
Covid 19 neutralizing antibody microlisaCovid 19 neutralizing antibody microlisa
Covid 19 neutralizing antibody microlisa
 
BASIC BIOLOGY OF HIV
BASIC BIOLOGY OF HIVBASIC BIOLOGY OF HIV
BASIC BIOLOGY OF HIV
 
Corona
CoronaCorona
Corona
 
SARS-CoV-2 Introduction_Creative Biolabs
SARS-CoV-2 Introduction_Creative BiolabsSARS-CoV-2 Introduction_Creative Biolabs
SARS-CoV-2 Introduction_Creative Biolabs
 
Covid-19 Drugs and their Mechanism of Action
Covid-19 Drugs and their Mechanism of ActionCovid-19 Drugs and their Mechanism of Action
Covid-19 Drugs and their Mechanism of Action
 
Covid 19 Antigen Card (RAT)
Covid 19 Antigen Card (RAT)Covid 19 Antigen Card (RAT)
Covid 19 Antigen Card (RAT)
 
Omicron variant
Omicron variantOmicron variant
Omicron variant
 
ACE2 AND TMPRSS2 RECEPTOR
ACE2 AND TMPRSS2 RECEPTORACE2 AND TMPRSS2 RECEPTOR
ACE2 AND TMPRSS2 RECEPTOR
 
Delta varient ppt
Delta varient pptDelta varient ppt
Delta varient ppt
 
Covid vaccine
Covid vaccineCovid vaccine
Covid vaccine
 
Aids and hiv
Aids and hivAids and hiv
Aids and hiv
 
Hiv
HivHiv
Hiv
 
Host response and diagnostic approaches of SARS-COV-2
Host response and diagnostic approaches of SARS-COV-2Host response and diagnostic approaches of SARS-COV-2
Host response and diagnostic approaches of SARS-COV-2
 
Pathogenisis of aids
Pathogenisis of aidsPathogenisis of aids
Pathogenisis of aids
 
Omicron variant
Omicron variantOmicron variant
Omicron variant
 

Viewers also liked (13)

Bronquilitis, laringotraqueitis y tos ferina
Bronquilitis, laringotraqueitis y tos ferinaBronquilitis, laringotraqueitis y tos ferina
Bronquilitis, laringotraqueitis y tos ferina
 
Croup by arif khan
Croup by arif khanCroup by arif khan
Croup by arif khan
 
Otho myx
Otho myxOtho myx
Otho myx
 
Molecular diagnostics in the future July 14 - Prof. Bert Niesters
Molecular diagnostics in the future July 14 - Prof. Bert NiestersMolecular diagnostics in the future July 14 - Prof. Bert Niesters
Molecular diagnostics in the future July 14 - Prof. Bert Niesters
 
croup
croupcroup
croup
 
Human para influenza virus
Human para influenza virusHuman para influenza virus
Human para influenza virus
 
Blt19 14 Jan 09 A Prof Raymond Lin Respiratory Tract Infections
Blt19   14 Jan 09   A Prof Raymond Lin   Respiratory Tract InfectionsBlt19   14 Jan 09   A Prof Raymond Lin   Respiratory Tract Infections
Blt19 14 Jan 09 A Prof Raymond Lin Respiratory Tract Infections
 
Viral infection of the respiratory tract (2)
Viral infection of the respiratory tract (2)Viral infection of the respiratory tract (2)
Viral infection of the respiratory tract (2)
 
Layrngeal pathologiess
Layrngeal pathologiessLayrngeal pathologiess
Layrngeal pathologiess
 
Croup
Croup Croup
Croup
 
Croup
CroupCroup
Croup
 
6. Virus Parainfluenza
6.  Virus Parainfluenza6.  Virus Parainfluenza
6. Virus Parainfluenza
 
Respiratory Diseases
Respiratory DiseasesRespiratory Diseases
Respiratory Diseases
 

Similar to John Short 2nd Year PhD Conference Poster

Human Immunodeficiency Virus
Human Immunodeficiency VirusHuman Immunodeficiency Virus
Human Immunodeficiency Virus
promotemedical
 
Microbiology hiv-yf
Microbiology   hiv-yfMicrobiology   hiv-yf
Microbiology hiv-yf
MBBS IMS MSU
 

Similar to John Short 2nd Year PhD Conference Poster (20)

HIV and AIDS /prosthodontic courses
HIV and AIDS /prosthodontic coursesHIV and AIDS /prosthodontic courses
HIV and AIDS /prosthodontic courses
 
HIV
HIVHIV
HIV
 
About human immunodeficiency virus (HIV)
About  human immunodeficiency virus (HIV)About  human immunodeficiency virus (HIV)
About human immunodeficiency virus (HIV)
 
JALS Final Thesis
JALS Final ThesisJALS Final Thesis
JALS Final Thesis
 
Hiv
HivHiv
Hiv
 
6 immunology-csbrp
6 immunology-csbrp6 immunology-csbrp
6 immunology-csbrp
 
Antiviral drugs
Antiviral drugsAntiviral drugs
Antiviral drugs
 
HIV by Dr. Rakesh Prasad Sah
HIV by Dr. Rakesh Prasad SahHIV by Dr. Rakesh Prasad Sah
HIV by Dr. Rakesh Prasad Sah
 
HIV - Human Immunodeficiency Virus
HIV - Human Immunodeficiency VirusHIV - Human Immunodeficiency Virus
HIV - Human Immunodeficiency Virus
 
HIV/AIDS
HIV/AIDSHIV/AIDS
HIV/AIDS
 
Anti-HIV standard regimens and newer drugs
Anti-HIV standard regimens and newer drugsAnti-HIV standard regimens and newer drugs
Anti-HIV standard regimens and newer drugs
 
Hiv
HivHiv
Hiv
 
Microbiology of HIV VIRUSES
Microbiology of HIV VIRUSESMicrobiology of HIV VIRUSES
Microbiology of HIV VIRUSES
 
2.HIV infections.ppt
2.HIV infections.ppt2.HIV infections.ppt
2.HIV infections.ppt
 
Human Immunodeficiency Virus
Human Immunodeficiency VirusHuman Immunodeficiency Virus
Human Immunodeficiency Virus
 
AIDS
AIDSAIDS
AIDS
 
Aids and hepatits
Aids and hepatitsAids and hepatits
Aids and hepatits
 
Human Immunodeficiency virus , (AIDS)
Human Immunodeficiency virus , (AIDS)Human Immunodeficiency virus , (AIDS)
Human Immunodeficiency virus , (AIDS)
 
Microbiology hiv-yf
Microbiology   hiv-yfMicrobiology   hiv-yf
Microbiology hiv-yf
 
HIV & AIDS..ppt
HIV & AIDS..pptHIV & AIDS..ppt
HIV & AIDS..ppt
 

More from John Alexander Logan Short

More from John Alexander Logan Short (6)

John A L Short Project Summary
John A L Short Project SummaryJohn A L Short Project Summary
John A L Short Project Summary
 
John Short Presentation
John Short PresentationJohn Short Presentation
John Short Presentation
 
Final GSK John A L Short Report
Final GSK John A L Short ReportFinal GSK John A L Short Report
Final GSK John A L Short Report
 
John Short GSK SGM 2007 Research Poster
John Short GSK SGM 2007 Research PosterJohn Short GSK SGM 2007 Research Poster
John Short GSK SGM 2007 Research Poster
 
John Short dissertation poster
John Short dissertation posterJohn Short dissertation poster
John Short dissertation poster
 
John Short Leeds Dissertation
John Short Leeds DissertationJohn Short Leeds Dissertation
John Short Leeds Dissertation
 

John Short 2nd Year PhD Conference Poster

  • 1. Sensing Parainfluenza virus infection: The role of RIG-I and MDA5 John A L Short, Rick Randall E-mail: jals4@st-andrews.ac.uk Parainfluenza: The Essentials What is a Parainfluenza virus?  Parainfluenza virus (PIV) is a single stranded, RNA negative sense virus  Infects the upper and lower respiratory tract Who is at risk of infection?  All children are infected at some stage  Immunocompromised patients e.g. AIDS What are the symptoms?  Severe fever, coughing, sneezing, croup There are NO antiviral drugs or vaccines 1 RIG-I and MDA5: viral sensors RIG-I detects short double stranded viral RNA and 5’ triphosphate capped single stranded viral RNA MDA5 detects viral long double stranded viral RNA RIG-I MDA5 IFNCell Antiviral IFN 2 Virus Infects Cell RIG-I and MDA5 sensors recognise viral RNA Sensors activate pathway for Interferon (IFN) expression IFN is secreted & absorbed by neighbouring uninfected cell Cell expresses antivirals, generating antiviral state Inhibition of viral replication upon viral infection 3 How do we visualise infection? Plaque Assay  Plaques formed from virus spreading from infected cell to neighbouring cells over 10 days  Use cells that “knock down” or decrease levels of RIG-I and MDA5  2o Antibody conjugated to alkaline phosphatase that reacts with substrate to stain plaques black  A549 NPro cells is a +ve control: NPro inhibits IFN expression Immunofluorescence  Cells infected for 2 days  Marker for IFN signalling to neighbouring cells: cellular antiviral MxA stained with Cy5  Cells express Green Fluorescent Protein (GFP) when IFN is induced  2o Antibody conjugated to fluorophore Texas Red Plaque 2 MergeAnti-MxAAnti-PIV5GFP Plaque 1 4 Mock GFP +IFN-IFNAnti-PIV5 Immunofluorescence - AIM: To determine the IFN response to PIV5 infection Key: Green = GFP; Red = Viral NP; Blue = Antiviral MxA  Adding IFN to cells induces expression of antiviral MxA  PIV5 infects cells, forming a plaque  No IFN induction = no MxA expression  IFN expressing cells leads to induction of MxA in neighbouring uninfected cells  Heterogeneous cellular response: Only some cells express IFN, the majority respond to IFN signaling  Infect monolayer of A549 alveolar epithelial cells with PIV5 NPro +ve Control Naïve MDA5 KD RIG-I KD RIG-I/ MDA5 KD 0 0.5 1 1.5 2 2.5 3 Naïve MDA5KD RIG-IKD RIG- I/MDA5 KD Npro+ve Control Relative sizes of largest plaques following PIV5 infection PlaquesizerelativetoNaive 5 Plaque Assay - AIM: To visualise virus infection in cells lacking RIG-I and MDA5  Naïve and MDA5 knock down (KD) cell lines had similar plaque sizes after viral infection  RIG-I and the RIG-I/MDA5 double KD cells had larger plaque sizes than Naïve and MDA5 KD cells  In RIG-I KD and RIG-I/MDA5 KD cells, plaques were different sizes, indicating asynchronous viral IFN evasion 6 What does the data mean?  IFN is expressed in some cells following virus infection  Plaque assay data suggests that RIG-I is more important than MDA5 in sensing PIV infection The Future:  Why is there a heterogeneous cellular response to virus infection?  Are there differences in the number IFN expressing cells between RIG-I KD and MDA5 KD cell lines? 7 Reference Randall, R. E. and S. Goodbourn (2008). "Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures." J Gen Virol 89(Pt 1): 1-47.  Stain cells with 1o antibody for virus nucleoprotein